Bleeding Prophylaxis in Bleeding Disorder Patients Undergoing GI Endoscopy

Publication Date: March 16, 2020

Key Points

Key Points

  • Low risk procedures like gastroscopy or colonoscopy without polypectomy have a bleeding risk between 0 and 0.02%.
  • In general, a number of variables increases the risk of bleeding, independent of an underlying bleeding disorder, including older age, male gender, polypectomy >7 mm, and colonoscopy performed by a low-volume endoscopist. The continued development of endoscopes and equipment is likely to reduce the bleeding risk further.
  • Three recent studies have provided detailed information on best prophylaxis practice for patients with bleeding disorders.
    • Infusing to a higher target of 80–100% and using concurrent tranexamic acid pre-procedure should be incorporated in any recommendations as well as infusing for 7–10 days if a high-risk procedure.

Treatment

...eatment...

...or All Bleeding Disorder Pa...

...tment with antifibrinolytic therapy,* continue fo...


...derate or Severe Hemophilia or Severe VWD on Proph...

...e moving the prophylactic factor dose to...


...he Non-inhibitor Hemophilia a Patient on Em...

...infusing with FVIII to goal 80–10...


...or Hemophilia a Patient on Emicizum...

...e rVIIa pre-procedure 90–120 mcg/kg and...


...n DDAVP Responsive Type 1 VWD, Low VWF or M...

...or IV DDAVP 60–90 min pre-procedure and co...


...ndoscopic Variceal Ligation or Hemorrhoidec...

...% pre-dose and continue to infuse daily × 7...


...r Mild Platelet Function Diso...

...ister IN/IV DDAVP 60–90 min pre-pro...


...evere Platelet Function Disorders (Glanzman...

...ter rVIIa 90–120 mcg/kg then q2h × 2 more d...


...Society of Gastrointestinal Endoscop...

...cedures Diagnostic endoscopy (EGD, colono...

...isk Procedures Polypectomy Biliary or pa...